These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6777009)

  • 1. A longitudinal study of urinary excretion of N,N,-dimethyltryptamine in psychotic patients.
    Checkley SA; Murray RM; Oon MC; Rodnight R; Birley JL
    Br J Psychiatry; 1980 Sep; 137():236-9. PubMed ID: 6777009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.
    Murray RM; Oon MC; Rodnight R; Birley JL; Smith A
    Arch Gen Psychiatry; 1979 Jun; 36(6):644-9. PubMed ID: 286576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary dimethyltryptamine and psychiatric symptomatology and classification.
    Rodnight R; Murray RM; Oon MC; Brockington IF; Nicholls P; Birley JL
    Psychol Med; 1976 Nov; 6(4):649-57. PubMed ID: 1070024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of dimethyltryptamine in liver disease.
    Checkley SA; Oon MC; Rodnight R; Murphy MP; Williams RS; Birley JL
    Am J Psychiatry; 1979 Apr; 136(4A):439-41. PubMed ID: 284722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The excretion of dimethyltryptamine in psychiatric patients.
    Murray RM; Oon MC
    Proc R Soc Med; 1976 Nov; 69(11):831-2. PubMed ID: 1070023
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects.
    Oon MC; Murray RM; Rodnight R; Murphy MP; Birley JL
    Psychopharmacology (Berl); 1977 Oct; 54(2):171-5. PubMed ID: 22091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine.
    Vitale AA; Pomilio AB; Cañellas CO; Vitale MG; Putz EM; Ciprian-Ollivier J
    J Nucl Med; 2011 Jun; 52(6):970-7. PubMed ID: 21622895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
    Huszka L; Zabek DH; Doust JW
    Can Psychiatr Assoc J; 1976 Dec; 21(8):541-6. PubMed ID: 1071579
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological heterogeneity in schizophrenic patients.
    Buchsbaum MS; Davis GC
    Am J Psychiatry; 1979 Dec; 136(12):1618. PubMed ID: 292318
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 11. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 12. Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring.
    Narasimhachari N; Himwich HE
    Biochem Biophys Res Commun; 1973 Dec; 55(4):1064-71. PubMed ID: 4520847
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat.
    Sitaram BR; Lockett L; Blackman GL; McLeod WR
    Biochem Pharmacol; 1987 Jul; 36(13):2235-7. PubMed ID: 3475068
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].
    Matsumoto H; Pietruszewska I
    Psychiatr Pol; 1978; 12(2):189-97. PubMed ID: 275869
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Urinary dimethyltryptamine in psychiatric patients.
    Oon MC; Murray RH; Brockington IF; Rodnight R; Birley JL
    Lancet; 1975 Dec; 2(7945):1146-7. PubMed ID: 53629
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylated psychotogens in the urine of psychiatric patients.
    Kanabus P; Krysa G; Matsumoto H; Stencka K
    Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered consciousness states and endogenous psychoses: a common molecular pathway?
    Ciprian-Ollivier J; Cetkovich-Bakmas MG
    Schizophr Res; 1997 Dec; 28(2-3):257-65. PubMed ID: 9468359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elimination of N,N-dimethyltryptamine by urine].
    Spatz N; Spatz H; Mesones Arroyo HL; Rosan T; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1993 Sep; 39(3):212-6. PubMed ID: 7905222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bufotenin-like substance in the urine of schizophrenics.
    Cottrell AC; Mcleod MF; Mcleod WR
    Am J Psychiatry; 1977 Mar; 134(3):322-2. PubMed ID: 265142
    [No Abstract]   [Full Text] [Related]  

  • 20. Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine.
    Räisänen M; Kärkkäinen J
    J Chromatogr; 1979 Apr; 162(4):579-84. PubMed ID: 118980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.